Company Filing History:
4 out of 78 
4 out of 4,455 
Years Active: 2009-2014
Title: Neil R Michaud: Innovator in Antibody Treatment Methods
Introduction
Neil R Michaud is a prominent inventor based in Pawcatuck, CT (US), known for his significant contributions to the field of biotechnology. He holds a total of four patents, focusing primarily on treatment methods using c-Met antibodies. His work has the potential to impact various therapeutic applications, particularly in the realm of cancer treatment.
Latest Patents
Michaud's latest patents include innovative methods related to antibodies that specifically bind to c-Met, a receptor tyrosine kinase implicated in cancer progression. His inventions encompass human antibodies and antigen-binding portions that inhibit c-Met activity. These patents also cover chimeric, bispecific, and single-chain antibodies, as well as methods for producing these antibodies and their use in diagnosis and treatment. Additionally, he has developed gene therapy methods utilizing nucleic acid molecules encoding immunoglobulin molecules that comprise human anti-c-Met antibodies. His work extends to the creation of transgenic animals or plants that incorporate these nucleic acid molecules.
Career Highlights
Throughout his career, Michaud has worked with leading biotechnology companies, including Amgen Fremont Inc. and Pfizer Corporation. His experience in these organizations has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his expertise in antibody development and therapeutic applications.
Collaborations
Michaud has collaborated with notable professionals in the field, including Shama Kajiji and Gary Borzillo. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Neil R Michaud's innovative work in the field of antibody treatment methods showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving therapeutic options for patients, particularly in the fight against cancer.